‘Ozempic Face’ Concern

Doctors are warning that fast weight loss on drugs like Ozempic and Wegovy can leave some patients with a hollow, sagging face that looks older. (clickondetroit.com) In a sponsored article published April 22, 2026, ClickOnDetroit cited Metro Detroit facial plastic surgeon Dr. Charles M. Boyd, who said the change shows up in the temples, under the eyes, and along the sides of the face. Boyd said rapid weight loss leaves skin “with nowhere to go.” (clickondetroit.com) The basic issue is not unique to one brand name. The American Society of Plastic Surgeons said in June 2025 that “Ozempic face” is shorthand for facial volume loss and skin laxity that can follow rapid weight loss on glucagon-like peptide-1 drugs, including semaglutide medicines and tirzepatide competitors. (plasticsurgery.org) Those medicines work by mimicking gut hormones that reduce appetite and, in some cases, slow stomach emptying. Wegovy is approved for chronic weight management and cardiovascular risk reduction in some adults with obesity or overweight, while Ozempic is approved to improve blood sugar in adults with type 2 diabetes. (wegovy.com) (ozempic.com) Plastic surgeons say the face can look older because fat pads in the cheeks and temples shrink faster than skin can tighten. The American Society of Plastic Surgeons said that mismatch can make wrinkles, hollow areas, and loose skin more visible. (plasticsurgery.org) Boyd said patients should think about prevention before major weight comes off, not after. He told ClickOnDetroit that injectables and biostimulators can be used earlier in a weight-loss plan to support collagen and elastin, though the station did not publish the underlying study details. (clickondetroit.com) The medical literature on the topic is still thin. A systematic review published June 11, 2025 in *Aesthetic Surgery Journal Open Forum* found 23 relevant articles and said available evidence was limited by study bias, even as reports of facial aging changes and public interest in fillers and plastic surgery were rising. (academic.oup.com) Drug labels do not list “Ozempic face” as a named adverse effect. The official prescribing information for Ozempic and Wegovy instead highlights risks such as thyroid tumor warnings, pancreatitis, gallbladder problems, and delayed stomach emptying. (ozempic.com) (wegovy.com) That leaves “Ozempic face” in a category doctors describe as a consequence of losing weight quickly, rather than a formal diagnosis. The closing message from surgeons has been consistent: patients who want the metabolic benefits of these drugs may also need a plan for how fast weight comes off — and what that does to the face. (plasticsurgery.org) (clickondetroit.com)